FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Clinical Scales in SMA: A Clinician Perspective

Activity Snapshot

Activity Type: 
On-Demand Webinar
Release Date: 
Thursday, December 5, 2024
Activity Overview: 

December 5th 1:00pm est